-
1
-
-
33644756801
-
Body mass index and risk for end-stage renal disease
-
Hsu CY, McCulloch CE, Iribarren C et al. Body mass index and risk for end-stage renal disease. Ann Intern Med, 2006; 144: 21-28. (Pubitemid 46780716)
-
(2006)
Annals of Internal Medicine
, vol.144
, Issue.1
, pp. 21-28
-
-
Hsu, C.-Y.1
McCulloch, C.E.2
Iribarren, C.3
Darbinian, J.4
Go, A.S.5
-
2
-
-
4644221457
-
Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization
-
Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization. N Engl J Med, 2004; 351: 1296-1305.
-
(2004)
N Engl J Med
, vol.351
, pp. 1296-1305
-
-
Go, A.S.1
Chertow, G.M.2
Fan, D.3
-
3
-
-
78650114674
-
Serum paraoxonase 1 activity in women with metabolic syndrome
-
Yilmaz H, Sayar N, Yilmaz M et al. Serum paraoxonase 1 activity in women with metabolic syndrome. Kardiol Pol, 2010; 68: 1219-1224.
-
(2010)
Kardiol Pol
, vol.68
, pp. 1219-1224
-
-
Yilmaz, H.1
Sayar, N.2
Yilmaz, M.3
-
4
-
-
77958516036
-
Serum uric acid levels predict the severity and morphology of coronary atherosclerosis detected by multidetector computed tomography
-
Kayaa EB, Yorguna H, Canpolata U et al. Serum uric acid levels predict the severity and morphology of coronary atherosclerosis detected by multidetector computed tomography. Atherosclerosis, 2010; 213: 178-183.
-
(2010)
Atherosclerosis
, vol.213
, pp. 178-183
-
-
Kayaa, E.B.1
Yorguna, H.2
Canpolata, U.3
-
5
-
-
0029098080
-
Uric acid and coronary heart disease risk: Evidence for a role of uric acid in the obesity-insulin resistance syndrome
-
Lee J, Sparrow D, Vokonas S, Landsberg L. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. Am J Epidemiol, 1995; 142: 3-8.
-
(1995)
Am J Epidemiol
, vol.142
, pp. 3-8
-
-
Lee, J.1
Sparrow, D.2
Vokonas, S.3
Landsberg, L.4
-
6
-
-
48049115805
-
Uric acid and incident kidney disease in the community
-
Weiner DE, Tighiouart H, Elsayed EF et al. Uric acid and incident kidney disease in the community. J Am Soc Nephrol, 2008; 19: 1204-1211.
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 1204-1211
-
-
Weiner, D.E.1
Tighiouart, H.2
Elsayed, E.F.3
-
7
-
-
31344447948
-
The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease
-
Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol, 2006; 97: 3A-11A.
-
(2006)
Am J Cardiol
, vol.97
-
-
Haffner, S.M.1
-
8
-
-
39749112610
-
Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome
-
Odrowa̧ż-Sypniewska G. Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome. Adv Med Scien, 2007; 52: 246-250.
-
(2007)
Adv Med Scien
, vol.52
, pp. 246-250
-
-
Odrowa̧z-Sypniewska, G.1
-
9
-
-
0033574249
-
A more accurate method to estimate glomerular filtration rate from serum creatinine. A new prediction equation
-
Modification of Diet in Renal Disease Study Group
-
Levey AS, Bosh JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine. A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med, 1999; 130: 461-470.
-
(1999)
Ann Intern Med
, vol.130
, pp. 461-470
-
-
Levey, A.S.1
Bosh, J.P.2
Lewis, J.B.3
-
10
-
-
1442334070
-
Predictors of New-Onset Kidney Disease in a Community-Based Population
-
DOI 10.1001/jama.291.7.844
-
Fox CS, Larson MG, Leip EP et al. Predictors of new-onset kidney disease in a community-based population. JAMA, 2004; 291: 844-850. (Pubitemid 38543772)
-
(2004)
Journal of the American Medical Association
, vol.291
, Issue.7
, pp. 844-850
-
-
Fox, C.S.1
Larson, M.G.2
Leip, E.P.3
Culleton, B.4
Wilson, P.W.F.5
Levy, D.6
-
11
-
-
33646898442
-
Obesity and risk for chronic renal failure
-
DOI 10.1681/ASN.2005060638
-
Ejerbald E, Fored CM, Lindblad P et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol, 2006; 17: 1695-1702. (Pubitemid 43794672)
-
(2006)
Journal of the American Society of Nephrology
, vol.17
, Issue.6
, pp. 1695-1702
-
-
Ejerblad, E.1
Fored, C.M.2
Lindblad, P.3
Fryzek, J.4
McLaughlin, J.K.5
Nyren, O.6
-
12
-
-
0142058881
-
Lifestyle factors, obesity and the risk of chronic kidney disease
-
DOI 10.1097/01.EDE.0000071413.55296.c4
-
Stengel B, Tarver-Carr ME, Powe NR et al. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology, 2003; 14: 479-487. (Pubitemid 40417067)
-
(2003)
Epidemiology
, vol.14
, Issue.4
, pp. 479-487
-
-
Stengel, B.1
Tarver-Carr, M.E.2
Powe, N.R.3
Eberhardt, M.S.4
Brancati, F.L.5
-
13
-
-
0037386140
-
A central body fat distribution is related to renal function impairment, even in lean subjects
-
Pinto-Sietsma SJ, Navis G, Jansen WM et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis, 2003; 41: 733-741. (Pubitemid 36401550)
-
(2003)
American Journal of Kidney Diseases
, vol.41
, Issue.4
, pp. 733-741
-
-
Pinto-Sietsma, S.-J.1
Navis, G.2
Janssen, W.M.T.3
De Zeeuw, D.4
Gans, R.O.B.5
De Jong, P.E.6
-
14
-
-
0032938267
-
Insulin-like growth factor I improves renal function in patients with end-stage chronic renal failure
-
Vijayan A, Franklin SC, Behrend T et al. Insulin-like growth factor I improves renal function in patients with end-stage chronic renal failure. Am J Physiol, 1999; 276: R929-R934. (Pubitemid 29214161)
-
(1999)
American Journal of Physiology - Regulatory Integrative and Comparative Physiology
, vol.276
, Issue.4
-
-
Vijayan, A.1
Franklin, S.C.2
Behrend, T.3
Hammerman, M.R.4
Miller, S.B.5
-
15
-
-
0037309569
-
Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies
-
DOI 10.1053/ajkd.2003.50039
-
Morales E, Valero MA, Leon M et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis, 2003; 41: 319-327. (Pubitemid 36152449)
-
(2003)
American Journal of Kidney Diseases
, vol.41
, Issue.2
, pp. 319-327
-
-
Morales, E.1
Valero, M.A.2
Leon, M.3
Hernandez, E.4
Praga, M.5
-
16
-
-
0033920866
-
Plasma lipids and risk of developing renal dysfunction: The atherosclerosis risk in communities study
-
Muntner P, Coresh J, Smith JC et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int, 2000; 58: 1908-1919.
-
(2000)
Kidney Int
, vol.58
, pp. 1908-1919
-
-
Muntner, P.1
Coresh, J.2
Smith, J.C.3
-
17
-
-
0037840403
-
Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women: A Randomized Trial
-
DOI 10.1001/jama.289.14.1799
-
Esposito K, Pontillo A, Di Palo C et al. Effect of weight loss and lifestyle changes on vascular inflammatory makers in obese women: a randomised trial. JAMA, 2003; 289: 1799-1804. (Pubitemid 37430249)
-
(2003)
Journal of the American Medical Association
, vol.289
, Issue.14
, pp. 1799-1804
-
-
Esposito, K.1
Pontillo, A.2
Di, P.C.3
Giugliano, G.4
Masella, M.5
Marfella, R.6
Giugliano, D.7
-
18
-
-
0037022237
-
Weight loss reduces C-reactive protein levels in obese postmenopausal women
-
DOI 10.1161/hc0502.103331
-
Tchernof P, Nolan A, Sites CK et al. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation, 2002; 105: 564-569. (Pubitemid 34123429)
-
(2002)
Circulation
, vol.105
, Issue.5
, pp. 564-569
-
-
Tchernof, A.1
Nolan, A.2
Sites, C.K.3
Ades, P.A.4
Poehlman, E.T.5
-
19
-
-
77956398698
-
C-reactive protein is a mediator of cardiovascular disease
-
Bisoendial RJ, Boekholdt SM, Vergeer1 M et al. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J, 2009; 31: 2087-2091.
-
(2009)
Eur Heart J
, vol.31
, pp. 2087-2091
-
-
Bisoendial, R.J.1
Boekholdt, S.M.2
Vergeer, M.3
-
20
-
-
33646674298
-
Unearthing uric acid: An ancient factor with recently found significance in renal and cardiovascular disease
-
DOI 10.1038/sj.ki.5000391, PII 5000391
-
Nakagawa T, Kang DH, Feig D et al. Unearthing uric acid: An ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int, 2006; 69: 1722-1725. (Pubitemid 43739197)
-
(2006)
Kidney International
, vol.69
, Issue.10
, pp. 1722-1725
-
-
Nakagawa, T.1
Kang, D.-H.2
Feig, D.3
Sanchez-Lozada, L.G.4
Srinivas, T.R.5
Sautin, Y.6
Ejaz, A.A.7
Segal, M.8
Johnson, R.J.9
-
21
-
-
33845895003
-
Association between serum uric acid level and components of the metabolic syndrome
-
Lin S-D, Tsai D-H, Hsu S-R. Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc, 2006; 69: 512-516. (Pubitemid 46017171)
-
(2006)
Journal of the Chinese Medical Association
, vol.69
, Issue.11
, pp. 512-516
-
-
Lin, S.-D.1
Tsai, D.-H.2
Hsu, S.-R.3
-
22
-
-
33645560926
-
A causal role for uric acid in fructose-induced metabolic syndrome
-
DOI 10.1152/ajprenal.00140.2005
-
Nakagawa T, Hu H, Zharikov S et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol, 2006; 290: F625-F631. (Pubitemid 43724964)
-
(2006)
American Journal of Physiology - Renal Physiology
, vol.290
, Issue.3
-
-
Nakagawa, T.1
Hu, H.2
Zharikov, S.3
Tuttle, K.R.4
Short, R.A.5
Glushakova, O.6
Ouyang, X.7
Feig, D.I.8
Block, E.R.9
Herrera-Acosta, J.10
Patel, J.M.11
Johnson, R.J.12
-
23
-
-
0026325211
-
Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration
-
Faccini F, Chen YD, Hollenbeck CB et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA, 1999; 266: 3008-3011.
-
(1999)
JAMA
, vol.266
, pp. 3008-3011
-
-
Faccini, F.1
Chen, Y.D.2
Hollenbeck, C.B.3
-
24
-
-
4544313843
-
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort
-
DOI 10.1053/j.ajkd.2004.06.006, PII S0272638604009345
-
Iseki K, Ikemiya Y, Inoue T et al. Significance of hyperuricemia as a risk factor for developing ERDS in a screened cohort. Am J Kidney Dis, 2004; 44: 642-650. (Pubitemid 39237608)
-
(2004)
American Journal of Kidney Diseases
, vol.44
, Issue.4
, pp. 642-650
-
-
Iseki, K.1
Ikemiya, Y.2
Inoue, T.3
Iseki, C.4
Kinjo, K.5
Takishita, S.6
-
25
-
-
77955729725
-
Effect of allopurinol in chronic kidney disease progression and cardiovascular risk
-
Goicoechea M, García de Vinuesa S, Verdalles U et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol, 2010; 5: 1388-1393.
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 1388-1393
-
-
Goicoechea, M.1
García De Vinuesa, S.2
Verdalles, U.3
-
26
-
-
0037078969
-
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
-
DOI 10.1056/NEJMoa021993
-
Ridker PM, Rifai N, Rose L et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular event. N Engl J Med, 2002; 347: 1557-1565. (Pubitemid 35315836)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.20
, pp. 1557-1565
-
-
Ridker, P.M.1
Rifai, N.2
Rose, L.3
Buring, J.E.4
Cook, N.R.5
-
27
-
-
0142087611
-
Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells
-
DOI 10.1161/01.CIR.0000096055.62724.C5
-
Calabro P, Willerson JT, Eh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation, 2003; 108: 1930-1932. (Pubitemid 37296536)
-
(2003)
Circulation
, vol.108
, Issue.16
, pp. 1930-1932
-
-
Calabro, P.1
Willerson, J.T.2
Yeh, E.T.H.3
-
28
-
-
33646748459
-
Uric acid and inflammatory markers
-
Ruggiero C, Cherubini A, Ble A et al. Uric acid and inflammatory markers. Eur Heart J, 2006; 27: 1174-1181.
-
(2006)
Eur Heart J
, vol.27
, pp. 1174-1181
-
-
Ruggiero, C.1
Cherubini, A.2
Ble, A.3
-
29
-
-
33645461474
-
Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells
-
Kang DH, Park SK, Lee IK et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol, 2005; 16: 3553-3562.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 3553-3562
-
-
Kang, D.H.1
Park, S.K.2
Lee, I.K.3
-
30
-
-
13144253218
-
Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle
-
Hayden MR, Tyagi SC. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutrition Metabolism, 2004; 1: 1-15.
-
(2004)
Nutrition Metabolism
, vol.1
, pp. 1-15
-
-
Hayden, M.R.1
Tyagi, S.C.2
-
31
-
-
0038579374
-
Uric acid stimulates MCP-1 production in vascular smooth muscle cells via MAPK and COX-2
-
Kannelis J, Watanabe S, Li JH et al. Uric acid stimulates MCP-1 production in vascular smooth muscle cells via MAPK and COX-2. Hypertension, 2003; 41: 1287-1293.
-
(2003)
Hypertension
, vol.41
, pp. 1287-1293
-
-
Kannelis, J.1
Watanabe, S.2
Li, J.H.3
-
32
-
-
0037469261
-
C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells. Implication for the metabolic syndrome and atherothrombosis
-
Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells. Implication for the metabolic syndrome and atherothrombosis. Circulation, 2003; 107: 398-404.
-
(2003)
Circulation
, vol.107
, pp. 398-404
-
-
Devaraj, S.1
Xu, D.Y.2
Jialal, I.3
|